These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 639280)

  • 1. Cross reactivity of digitoxin and spironolactone in two radioimmunoassays for serum digoxin.
    Müller H; Bräuer H; Resch B
    Clin Chem; 1978 Apr; 24(4):706-9. PubMed ID: 639280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reassessment of cross-reactivity of spironolactone metabolites with four digoxin immunoassays.
    Pleasants RA; Williams DM; Porter RS; Gadsden RH
    Ther Drug Monit; 1989; 11(2):200-4. PubMed ID: 2655203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical appraisal of a further three new commercial digoxin radioimmunoassay kits with reference to cross-reacting substances.
    Wood WG; Wachter C
    J Clin Chem Clin Biochem; 1979 Feb; 17(2):77-83. PubMed ID: 422947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of digoxin by radioimmunoassay.
    Walsh PR; Crawford JF; Hawker CD
    Ann Clin Lab Sci; 1977; 7(1):79-87. PubMed ID: 836005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors of importance for valid digitalis assays particularly for the determination of digoxin in plasma and urine.
    Molin L
    Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 4():1-62. PubMed ID: 3739734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some factors affecting a commercial kit for radioimmunoassay of digoxin using tritiated digoxin.
    Boink AB; Kruyswijk HH; Willebrands AF; Maas AH
    J Clin Chem Clin Biochem; 1977 May; 15(5):261-6. PubMed ID: 894193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proceedings: Preparation and characteristics of an antigitaloxigenin for the study of the pharmacodynamics of gitaloxine and pentaformylgitoxine].
    Lesne M; Dolphen R
    Arch Int Physiol Biochim; 1975 Feb; 83(1):136-8. PubMed ID: 50774
    [No Abstract]   [Full Text] [Related]  

  • 8. Variable cross-reactivity of digoxin metabolites in digoxin immunoassays.
    Valdes R; Brown BA; Graves SW
    Am J Clin Pathol; 1984 Aug; 82(2):210-3. PubMed ID: 6380268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A simplified radioimmunoassay for digoxin determination using a 125-j-labelled, solid-phase kit (author's transl)].
    Doering W; Blümel E
    Klin Wochenschr; 1978 May; 56(10):497-502. PubMed ID: 651281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contribution of serum determinations of digitoxin and digoxin by radioimmunoassay in acute digitalis poisoning].
    Ducloux G; Dessaint JP; Warembourg H
    Lille Med; 1977 Jan; 22(1):56-9. PubMed ID: 846291
    [No Abstract]   [Full Text] [Related]  

  • 11. Spironolactone as a source of interference in commercial digoxin immunoassays.
    Morris RG; Lagnado PY; Lehmann DR; Frewin DB; Glistak ML; Burnet RB
    Ther Drug Monit; 1987 Jun; 9(2):208-11. PubMed ID: 3617160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of digoxin in serum. Comparison of radioimmunoassay and a heterogeneous enzyme immunoassay (author's transl)].
    Borner K; Rietbrock N
    J Clin Chem Clin Biochem; 1978 Jun; 16(6):335-42. PubMed ID: 353220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferences and recovery of digitalis glycoside preparations using commercial radioimmunoassay kits for digoxin and digitoxin.
    Kinsun H; Moulin MA
    J Med; 1977; 8(6):425-34. PubMed ID: 272436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonradioactive serum digoxin and digitoxin levels.
    Shapiro W; Taubert K; Narahara K
    Arch Intern Med; 1972 Jul; 130(1):31-6. PubMed ID: 5035980
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of digoxin levels in blood by the radioimmunoassay method].
    Maitre Azcárate MJ; de Artaza Andrade M; Marquez Montes J; Martín Judez V; Fernández de Miguel JM; Valles Belsue F; Arnáiz A; Botello A
    Rev Esp Cardiol; 1974; 27(3):245-50. PubMed ID: 4438768
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of assay conditions on cross reactivity of digoxin-like immunoreactive substance(s) with radioimmunoassay kits.
    Pudek MR; Seccombe DW; Jacobson BE; Humphries K
    Clin Chem; 1985 Nov; 31(11):1806-10. PubMed ID: 4053349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reactivity of derivatives of digoxin and digitoxin as measured by the Na-K-atpase displacement assay and by radioimmunoassay.
    Marcus FI; Ryan JN; Stafford MG
    J Lab Clin Med; 1975 Apr; 85(4):610-20. PubMed ID: 123547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference between eplerenone and digoxin in fluorescence polarization immunoassay, microparticle enzyme immunoassay, and affinity column-mediated immunoassay.
    Yamada T; Suzuki K; Iguchi K; Kanada Y; Kato R; Ijiri Y; Nishihara M; Murakami S; Hayashi T; Tamai H; Tanaka K
    Ther Drug Monit; 2010 Dec; 32(6):774-7. PubMed ID: 20625353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunoassay of digoxin and digitoxin.
    Besch HR; Watanabe AM
    Clin Chem; 1975 Nov; 21(12):1815-29. PubMed ID: 1183006
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of spironolactone and its metabolite canrenone on serum digoxin assays.
    Foukaridis GN
    Ther Drug Monit; 1990 Jan; 12(1):82-4. PubMed ID: 2305425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.